Structural Characterization of Cis– and Trans–Pt(NH(3))(2)Cl(2) Conjugations with Chitosan Nanoparticles

The conjugation of chitosan 15 and 100 KD with anticancer drugs cis– and trans–Pt (NH(3))(2)Cl(2) (abbreviated cis–Pt and trans–Pt) were studied at pH 5–6. Using multiple spectroscopic methods and thermodynamic analysis to characterize the nature of drug–chitosan interactions and the potential application of chitosan nanoparticles in drug delivery. Analysis showed that both hydrophobic and hydrophilic contacts are involved in drug–polymer interactions, while chitosan size and charge play a major role in the stability of drug–polymer complexes. The overall binding constants are K(ch–15–cis–Pt) = 1.44 (±0.6) × 10(5) M(−1), K(ch–100–cis–Pt) = 1.89 (±0.9) × 10(5) M(−1) and K(ch–15–trans–Pt) = 9.84 (±0.5) × 10(4) M(−1), and K(ch–100–trans–Pt) = 1.15 (±0.6) × 10(5) M(−1). More stable complexes were formed with cis–Pt than with trans–Pt–chitosan adducts, while stronger binding was observed for chitosan 100 in comparison to chitosan 15 KD. This study indicates that polymer chitosan 100 is a stronger drug carrier than chitosan 15 KD in vitro.